SIM
XLRN

Spark Investment Management’s Acceleron Pharma XLRN Stock Holding History

Spark Investment Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,900
Closed -$418K – 579
2019
Q4 		$418K Hold
7,900
– – 0.05% 365
2019
Q3 		$312K Sell
7,900
-57,500
-88% -$2.49M 0.04% 291
2019
Q2 		$2.69M Sell
65,400
-18,600
-22% -$770K 0.19% 168
2019
Q1 		$3.91M Buy
+84,000
New +$3.69M 0.18% 162
2014
Q2 		– Sell
-16,500
Closed -$569K – 774
2014
Q1 		$569K Buy
+16,500
New +$745K 0.09% 321

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Spark Investment Management's XLRN Position: Q1 2020 in Review

Spark Investment Management sold out of Acceleron Pharma (XLRN) in Q1 2020, closing a stake of 7,900 shares — an estimated $418K sold.

Spark Investment Management first reported a position in XLRN in Q1 2014 and held it in 5 quarters. The position peaked at $3.91M in Q1 2019. 217 funds tracked by Wall St. Rank hold XLRN as of Q1 2020.

  • Spark Investment Management reported no remaining Acceleron Pharma position as of Q1 2020 after selling out during the quarter.
  • Spark Investment Management sold 7,900 Acceleron Pharma shares in Q1 2020, an estimated $418K.
  • Spark Investment Management first reported a position in Acceleron Pharma in Q1 2014 and held it in 5 quarters.
  • Spark Investment Management's Acceleron Pharma position peaked at $3.91M in Q1 2019.
  • 217 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.